ST MARY'S SURGERY — All Prescriptions & Medications — Page 2
Practice Code: J82103 | ANDOVER, SP10 1DP
Showing results 51-100 of 631
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Edoxaban | 884 | 43.3K | £72.0K | +26.2% ▲ |
| 875 | 88.7K | £9.0K | +2,057.3% ▲ | |
| Mometasone furoate | 860 | 1,052 | £8.2K | +114.2% ▲ |
| Senna | 855 | 55.0K | £1.2K | +42.1% ▲ |
| Other emollient preparations | 825 | 465.1K | £5.9K | +37.4% ▲ |
| Lamotrigine | 824 | 72.4K | £13.8K | +39.5% ▲ |
| Progesterone | 806 | 74.4K | £15.3K | +92.6% ▲ |
| Empagliflozin | 801 | 39.8K | £49.5K | +28.0% ▲ |
| Tramadol hydrochloride | 798 | 65.3K | £4.2K | +11.3% ▲ |
| Codeine phosphate | 784 | 50.6K | £1.7K | +9.1% ▲ |
| Dapagliflozin | 771 | 36.4K | £45.2K | -38.4% ▼ |
| Montelukast | 760 | 29.3K | £1.6K | +11.0% ▲ |
| Fluoxetine hydrochloride | 760 | 43.8K | £1.3K | -25.1% ▼ |
| Hydrocortisone | 748 | 22.6K | £4.5K | +66.8% ▲ |
| Diclofenac diethyl | 746 | 92.0K | £6.1K | +110.1% ▲ |
| Nitrofurantoin | 731 | 11.1K | £9.1K | +53.2% ▲ |
| Flucloxacillin sodium | 728 | 24.8K | £1.4K | +61.9% ▲ |
| Solifenacin | 728 | 35.4K | £1.3K | +52.6% ▲ |
| 727 | 13.0K | £8.6K | +9.4% ▲ | |
| Doxazosin mesilate | 725 | 53.1K | £1.6K | -32.1% ▼ |
| Combined ethinylestradiol 30mcg | 688 | 56.6K | £3.4K | +147.7% ▲ |
| 684 | 2,126 | £74.4K | +25.5% ▲ | |
| Methotrexate | 653 | 12.3K | £16.1K | +100.6% ▲ |
| Ferrous fumarate | 640 | 47.0K | £1.8K | -11.7% ▼ |
| Sumatriptan succinate | 624 | 5,924 | £2.2K | +76.2% ▲ |
| Sildenafil (Erectile Dysfunction) | 620 | 8,320 | £2.1K | +23.0% ▲ |
| Latanoprost | 607 | 11.8K | £4.1K | +25.1% ▲ |
| Alendronic acid | 601 | 4,120 | £1.1K | -19.9% ▼ |
| Betamethasone valerate | 601 | 53.3K | £3.2K | +56.1% ▲ |
| 599 | 86.9K | £3.1K | +26.2% ▲ | |
| Insulin aspart | 598 | 4,661 | £26.2K | +57.0% ▲ |
| Atenolol | 581 | 31.3K | £683 | -3.6% ▼ |
| Alginic acid compound preparations | 577 | 307.6K | £5.4K | -1.5% vs avg |
| Estradiol | 571 | 13.9K | £7.0K | +111.6% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 561 | 57.7K | £2.7K | +212.2% ▲ |
| Cetirizine hydrochloride | 520 | 41.8K | £1.8K | +4.1% ▲ |
| Carbocisteine | 517 | 91.7K | £2.4K | -3.2% ▼ |
| Perindopril erbumine | 515 | 29.1K | £2.6K | -3.0% ▼ |
| Duloxetine hydrochloride | 497 | 23.0K | £1.6K | -21.8% ▼ |
| Morphine sulfate | 495 | 75.1K | £2.4K | -24.5% ▼ |
| Rosuvastatin calcium | 483 | 25.7K | £734 | -46.2% ▼ |
| Warfarin sodium | 479 | 34.4K | £1.2K | +1.6% vs avg |
| Lercanidipine hydrochloride | 469 | 25.3K | £2.5K | -24.1% ▼ |
| Loratadine | 466 | 27.6K | £629 | +123.0% ▲ |
| Bendroflumethiazide | 465 | 24.5K | £389 | -39.9% ▼ |
| Lisinopril | 464 | 23.2K | £534 | -57.7% ▼ |
| Rivaroxaban | 464 | 23.2K | £15.0K | -24.2% ▼ |
| Famotidine | 457 | 23.6K | £13.2K | -6.3% ▼ |
| 453 | 159.5K | £3.7K | +71.7% ▲ | |
| Linagliptin | 452 | 22.3K | £25.2K | +10.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.